Dr. Nikolas Fechner University of Tübingen, Germany

Nikolas Fechner is currently working in the computational drug discovery at Eli Lilly UK. He did his postgraduate research at the University of Tübingen on the application of kernel-based machine learning techniques in drug research, after finishing his Bioinformatics studies at the University of Tübingen.